After delivering a final offer of $1.2 billion, including debt, for Carmike Cinemas, AMC Theatres’ CEO Adam Aron said that he expects a “hysterical letter of protest to come out any second” from shareholders who think this new $33.06 a share offer is still too low.
“This new $33.06 price and 70-30 cash-stock mix is AMC’s best and final offer to acquire Carmike. This is it. We’re done. There’s no more water in this well.”
He went on to say that if the offer is rejected, AMC will move on to an offer to buy Europe’s largest chain, Odeon & UCI Cinemas Group.
Full Content: Deadline
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Italy Fines AI Chatbot Maker Replika €5 Million Over Privacy Violations
May 19, 2025 by
CPI
Germany’s Antitrust Chief: EU-US Tech Policy Divide Is Mostly Rhetoric
May 19, 2025 by
CPI
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas